Anyone from Amgen

Quote



anonymous said:
If, in fact, that’s even true regarding the training, then maybe it makes sense for your drug, but it does not for ours. Also, I will continue to use the term idiot when referencing “the OP from the other thread” or any anyone else from Amgen who comes on here and claims to have some special insight regarding what is going to happen to us, especially the OP who keeps regurgitating MY information as his or her own & then tacking on some speculative BS.
Clearly no one on here had insights from “high level meetings” given they didn’t even know the information that had already been decided and then made public. These Amgen idiots need to stop assuming that our situation will be similar to theirs and stop taking any little rumor that they hear about us as gospel.
Click to expand...

Um you guys hired low level reps as referral reps for Krystexxa. Its the same thing.
 


anonymous said:
If, in fact, that’s even true regarding the training, then maybe it makes sense for your drug, but it does not for ours. Also, I will continue to use the term idiot when referencing “the OP from the other thread” or any anyone else from Amgen who comes on here and claims to have some special insight regarding what is going to happen to us, especially the OP who keeps regurgitating MY information as his or her own & then tacking on some speculative BS.
Clearly no one on here had insights from “high level meetings” given they didn’t even know the information that had already been decided and then made public. These Amgen idiots need to stop assuming that our situation will be similar to theirs and stop taking any little rumor that they hear about us as gospel.
Click to expand...


OP here. No one ANYTHING! Just shut up! I'm the OP. I hate this board
 


anonymous said:
Um you guys hired low level reps as referral reps for Krystexxa. Its the same thing.
Click to expand...


Um, we transferred over some low level reps to some higher volume territories to call on PCPs to drive business INTO rheumatology - any rheumatology. There are no gout centers like there are vasculitis centers. Chemocentryx reps call on both rheumatology & Nephrology and there are SIGNIFICANTLY less reps than Horizon has.
Our rheumatology reps easily cover every rheumatology office in their geography.

It’s irrelevant anyway. None of that changes the fact that any Amgen or supposed Amgen employee on here has actually been correct about anything other than the basic benefits when it comes to what Horizon employees will receive or do going forward. They are not privy to a damn thing, Regarding the comment about us having targets in our backs and Amgen rheum reps getting trained on our drug, even if they are dumb enough to train your reps as some sort of referral rep, it doesn’t affect us. Our product, just like virtually every other one, is not that hard to learn, so it’s not like it gives anyone a leg up on replacing us even if there was a tiny chance that Enbrel or Otezla reps had any influence on us maintaining our positions, which there isn’t.

You can move on now.
 


anonymous said:
Um, we transferred over some low level reps to some higher volume territories to call on PCPs to drive business INTO rheumatology - any rheumatology. There are no gout centers like there are vasculitis centers. Chemocentryx reps call on both rheumatology & Nephrology and there are SIGNIFICANTLY less reps than Horizon has.
Our rheumatology reps easily cover every rheumatology office in their geography.

It’s irrelevant anyway. None of that changes the fact that any Amgen or supposed Amgen employee on here has actually been correct about anything other than the basic benefits when it comes to what Horizon employees will receive or do going forward. They are not privy to a damn thing, Regarding the comment about us having targets in our backs and Amgen rheum reps getting trained on our drug, even if they are dumb enough to train your reps as some sort of referral rep, it doesn’t affect us. Our product, just like virtually every other one, is not that hard to learn, so it’s not like it gives anyone a leg up on replacing us even if there was a tiny chance that Enbrel or Otezla reps had any influence on us maintaining our positions, which there isn’t.

You can move on now.
Click to expand...

Since your drug is easy to learn I'd say that makes you very replaceable
 




Tepezza is more about education. The sales force is twice the size it should be because of the IBU rollover. Originally, the plan was to hire a contract sales force for a year.

Krystexxa isn’t rare disease. Combine neph and rheum. Axe 75% and have the bone or rheum team get referrals.
 


anonymous said:
Tepezza is more about education. The sales force is twice the size it should be because of the IBU rollover. Originally, the plan was to hire a contract sales force for a year.

Krystexxa isn’t rare disease. Combine neph and rheum. Axe 75% and have the bone or rheum team get referrals.
Click to expand...

That's funny. The two recruiters that reached out via LinkedIn last week consider krystexxa rare disease.

The problem with your plan is the referral source isn't in a specialty they are already calling on.
 


anonymous said:
That's funny. The two recruiters that reached out via LinkedIn last week consider krystexxa rare disease.

The problem with your plan is the referral source isn't in a specialty they are already calling on.
Click to expand...

Uncontrolled gout isn’t a rare disease. Poorly managed or body isn’t responding to traditional treatment. Great product, though. Knee-capped by 340b pricing sanctioning, so limited promotability focuses on people using it to make money in their private clinics.
 


anonymous said:
Uncontrolled gout isn’t a rare disease. Poorly managed or body isn’t responding to traditional treatment. Great product, though. Knee-capped by 340b pricing sanctioning, so limited promotability focuses on people using it to make money in their private clinics.
Click to expand...

We have about 30k patients that could use our drug. It's rare usease. And it's not just promoted to individual physicians.
 






anonymous said:
Uncontrolled gout isn’t a rare disease. Poorly managed or body isn’t responding to traditional treatment. Great product, though. Knee-capped by 340b pricing sanctioning, so limited promotability focuses on people using it to make money in their private clinics.
Click to expand...

Another jackass who is too stupid to understand the demographics or is so entitled that they think they can change the FDA’s definition of rare disease. Pathetic
 











Write your reply...
Top Bottom
Back
Quote